Biocodex

Biocedex

Philippe Girard

Marie-Emmanuelle Le Guern

Bernard M Hublot

Jean-Marie Gillardin

Laurence Berthon-Cedille

Marc Verleye

The present invention relates to a compound of the following formula (I): or a pharmaceutically acceptable salt thereof, to be used in the prevention or treatment of light-induced damage and/or a degeneration of the retina in a patient.

Treatment of degenerations and light-induced damage to the retina

The present invention relates to yeast cells for use in the prevention or treatment of gastric or intestinal ulcers.

Medicinal product for treating gastrointestinal ulcers

The present invention relates to a pharmaceutical composition comprising as active substances: and

Synergistic combination of analgesic compounds

The present invention relates to a pharmaceutical composition comprising as active substances: and especially for its use in the prevention or treatment of pain.

The present invention relates to the use of at least one compound of formula (I) below: or at least one of the pharmaceutically acceptable salts thereof, for the preparation of a medicament intended for the prevention or for the treatment of cerebral edemas.

Pharmaceutical composition intended for the prevention or for the treatment of cerebral oedemas

This invention relates to the use of at least one compound of the following formula (I): or its pharmaceutically acceptable salts, for the preparation of a medicinal compound having neuroprotective activity intended to prevent or treat neurone deteriorations.

Neuroprotective compounds and pharmaceutical compositions comprising them

The present invention relates to the use of at least one compound of formula (I) below: or of its pharmaceutically acceptable salts, in the preparation of a medicament for the prevention or treatment of cerebral oedemas.

Growing community of inventors

Margny-les-Compiegne, France

Philippe Girard